FUR-EVER LOW PRICES ALL DAY, EVERYDAY
SENVELGO® (velagliflozin oral solution) is indicated to improve glycemic control in otherwise healthy cats with diabetes mellitus not previously treated with insulin.
SENVELGO® (velagliflozin oral solution) is a once-daily, liquid oral solution that can be administered directly into the cat’s mouth or applied onto a small amount of wet food.
SENVELGO® (velagliflozin oral solution) should be administered using the dosing syringe provided in the package. The dosing syringe fits onto the bottle and has a body weight scale with increments per pound of body weight. The dose should be rounded down to the nearest pound. After administration, close the bottle tightly with the cap. If needed, the syringe can be cleaned with a clean, dry cloth.
Contraindications: Do not use SENVELGO® (velagliflozin oral solution) in cats with diabetes mellitus who have previously been treated with insulin, who are receiving insulin, or in cats with insulin-dependent diabetes mellitus. The use of SENVELGO in cats with insulin-dependent diabetes mellitus, or the withdrawal of insulin and initiation of SENVELGO, is associated with an increased risk of diabetic ketoacidosis or euglycemic diabetic ketoacidosis and death.
Warnings:
User Safety Warnings: Not for use in humans. Keep out of reach of children.
Wash hands after use. This product may cause mild eye irritation. Avoid contact with eyes. If the product accidentally gets into the eyes, rinse eyes immediately with plenty of water; if wearing contact lenses, rinse the eyes first then remove contact lens(es) and continue to rinse for 5-10 minutes. If eye irritation continues or accidental ingestion occurs, seek medical advice and provide this product information to the physician. Exposure to product may induce local or systemic allergic reaction in sensitized individuals. Oral exposure to velagliflozin may cause transient effects such as increased renal glucose excretion, increased urine volume, and hypoglycemia.
IMPORTANT SAFETY INFORMATION: SENVELGO is indicated to improve glycemic control in otherwise healthy cats with diabetes mellitus not previously treated with insulin. Before using this product, it is important to read the entire product insert, including the boxed warning.
Cats treated with SENVELGO may be at an increased risk of diabetic ketoacidosis or euglycemic diabetic ketoacidosis, both of which may result in death. Development of these conditions should be treated promptly, including insulin administration and discontinuation of SENVELGO.
Do not use SENVELGO in cats with diabetes mellitus who have previously been treated with insulin, who are receiving insulin, or in cats with insulin-dependent diabetes mellitus. The use of SENVELGO in cats with insulin-dependent diabetes mellitus, or the withdrawal of insulin and initiation of SENVELGO, is associated with an increased risk of diabetic ketoacidosis or euglycemic diabetic ketoacidosis and death.
Sudden onset of hyporexia/anorexia, lethargy, dehydration, or weight loss in cats receiving SENVELGO should prompt immediate discontinuation of SENVELGO and assessment for diabetic ketoacidosis, regardless of blood glucose level. SENVELGO should not be initiated in cats with ketonuria, ketonemia, pancreatitis, anorexia, dehydration, or lethargy at the time of diagnosis of diabetes mellitus, as it may indicate the presence of other concurrent disease and increase the risk of diabetic ketoacidosis.
Keep SENVELGO in a secure location out of reach of children, dogs, cats, and other animals to avoid accidental ingestion or overdose. For more safety information, please see full prescribing information.
|
Image
 |
Effective Glycemic Control
SENVELGO oral solution has a minimal risk of clinical hypoglycemia and establishes effective glycemic control in as soon as 1 week of starting treatment.2,3
|
Image
 |
Liquid Oral Administration
The once-daily liquid oral solution requires less complex or intensive monitoring for stabilized cats. It can be administered directly into the cat’s mouth or applied onto a small amount of wet food.
|
Image
 |
No Refrigeration Needed
SENVELGO oral solution doesn’t require refrigeration before or after opening and has a 6-month shelf life once opened.2
Prescription Medications
PetPA facilitates the supply of restricted veterinary medicines (veterinary prescriptions) and is approved to do so by the Ministry of Primary Industries. When purchasing prescription medication through Your PetPA you know that:
All prescription medication listed on the PetPA website is available for supply on acceptance of your order by our team and on receipt of the original prescription.
